Iseki E

References (3)

Title : Efficacy and safety of donepezil in patients with dementia with Lewy bodies: results from a 12-week multicentre, randomised, double-blind, and placebo-controlled phase IV study - Mori_2024_Psychogeriatrics_24_542
Author(s) : Mori E , Ikeda M , Iseki E , Katayama S , Nagahama Y , Ohdake M , Takase T
Ref : Psychogeriatrics , 24 :542 , 2024
Abstract :
PubMedSearch : Mori_2024_Psychogeriatrics_24_542
PubMedID: 38439118

Title : Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan - Nozawa_2009_Psychogeriatrics_9_50
Author(s) : Nozawa M , Ichimiya Y , Nozawa E , Utumi Y , Sugiyama H , Murayama N , Iseki E , Arai H
Ref : Psychogeriatrics , 9 :50 , 2009
Abstract :
PubMedSearch : Nozawa_2009_Psychogeriatrics_9_50
PubMedID: 19604325

Title : Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease - Shiozaki_1999_J.Neurol.Neurosurg.Psychiatry_67_209
Author(s) : Shiozaki K , Iseki E , Uchiyama H , Watanabe Y , Haga T , Kameyama K , Ikeda T , Yamamoto T , Kosaka K
Ref : Journal of Neurology Neurosurg Psychiatry , 67 :209 , 1999
Abstract :
PubMedSearch : Shiozaki_1999_J.Neurol.Neurosurg.Psychiatry_67_209
PubMedID: 10406992